v3 Template
H

Hoth Therapeutics, Inc.

Biopharmaceuticals / Healthcare New York, USA ~240 employees
Founded
--
Employees (Est.)
~240
12 leaders known
Total Funding
$18.2M
Funding Rounds
4
Last Funding
2026-04-02

About Hoth Therapeutics, Inc.

Hoth Therapeutics is a biopharmaceutical company focused on developing innovative, impactful, and ground-breaking treatments with the goal of improving patient quality of life. They act as a catalyst in early-stage pharmaceutical research and development, advancing promising drugs from bench to pre-clinical and clinical testing.

Products & Services

Oncology Treatments:Therapeutics focused on addressing unmet needs in oncology.
Neurology Treatments:Innovative solutions targeting neurological conditions.
Inflammatory Treatments:Therapies aimed at treating inflammatory disorders.
Devices:Development of medical devices as part of their therapeutic offerings.
Pipeline (HT-001 and others):A range of drug candidates in development, including HT-001 for various skin-related conditions.

Specialties

Early-stage pharmaceutical research and development Oncology therapeutics Neurology therapeutics Inflammatory disorder treatments Dermatology treatments Medical devices Artificial Intelligence in drug development Oncology Neurology Inflammatory Dermatology

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Registered Direct Offering
T: -
FT: Registered Direct Offering
A: 2000000
MR: -
FA: Approximately $2.0 million
FAN: 2000000
D: 2026-04-02
FD: 2026-04-02
-
2 RT: Registered Direct Offering
T: -
FT: Registered Direct Offering
A: 2000000
MR: -
FA: 2.0 million
FAN: 2000000
D: 2026-04-01
FD: 2026-04-01
-
3 RT: Warrant Exercise
T: -
FT: Warrant Exercise
A: 4200000
MR: -
FA: 4.2 million
FAN: 4200000
D: 2024-03-27
FD: 2024-03-27
-
4 RT: Private Placement
T: -
FT: Private Placement
A: 10000000
MR: -
FA: $10 million
FAN: 10000000
D: 2023-01-03
FD: 2023-01-03
-
Registered Direct Offering Latest
2026-04-02
$2.0M
Registered Direct Offering 2026-04-01
$2.0M
Warrant Exercise 2024-03-27
$4.2M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

R

Robb Knie

Founder, President & Chief Executive Officer

R

Robb Knie

Founder, President & Chief Executive Officer

R

Robb Knie

Founder, President, and Chief Executive Officer

D

David Briones

Chief Financial Officer

H

Hayley Springer

Executive Vice President Operations

M

Mario Lacouture

View 9 more team members with Pro

Unlock Full Team Directory

Recent News

Hoth Therapeutics, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biopharmaceuticals / Healthcare
Company Size
~240 employees (est.)
Locations
New York, USA
New York

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro